Orgenesis Israel

Orgenesis Israel is owned by Orgenesis.

Orgenesis is a company listed under the stock ticker ORGS (US).

Orgenesis has a direct presence in 2 countries.

View the org chart displaying its 2 main executives

Most searched biographies at Orgenesis Israel

• Dan Slonim, General Manager
• Evan Fishman, Chief Financial Officer

Create your alert
to follow the executive moves at Orgenesis Israel.

Orgenesis has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).
• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Orgenesis Israel

Social media about Orgenesis Israel

• Orgenesis Israel on Wikipedia, Google News & Yahoo Finance
• Orgenesis Israel on LinkedIn, Twitter & YouTube

Contact by email its executives including Evan Fishman

View the org chart

Register to receive your alert

Report an error